ABSTRACT The present work involves the formulation of colon targeted matrix tablet of Mesalazine by using direct compression method. Excipients including in the formulation are Eudragit S100, Ethyl cellulose, Lactose, Talc, Magnesium stearate. Preformulation studies have also been performed to study the nature of API and compatibility of API with excipients by physical observation and TLC studies. The result showed that API was compatible with all the excipients selected. The tablets were formulated by direct compression method using the selected excipient quantities. The formulated tablets were tested for both pre-compression parameters and post compression parameters as per requirements of standards. Pre-compression parameters such as bu...
The Matrix Tablets each containing 50 mg of diclofenac sodium are prepared employing kollidonSR by d...
Objective: The present work was aimed at preparation of mesalazine microspheres by a non-aqueous sol...
ABSTRACT The main aim of the present work is to formulate and develop matrix tablets of Propranolol...
ABSTRACT The present work involves the formulation of colon targeted matrix tablet of Mesalazine by...
Mesalamine is a gold standard anti-inflammatory drug used to treat inflammatory bowel illnesses. It'...
In the present investigation an attempt was made to formulate the time and pH dependent drug deliver...
In the present investigation an attempt was made to formulate the time and pH dependent drug deliver...
In the present investigation an attempt was made to formulate the time and pH dependent drug deliver...
The main objective of this research paper is to formulate, evaluate and compare compression-coated t...
Gliclazide was formulated as a hydrophobic matrix sustained release tablet employing HPMC using diff...
The aim of the current work was to formulate as well as evaluate colon targeted matrix tablet using ...
ABSTRACT: Objective: The aim of this study is to develop an enteric coated (coated with Eudragit S-...
Abstract The system of drug delivery mainly depends on targeted therapy synthesis that is the formul...
Eudragit® NM was investigated as a matrix former in combination with microcrystalline cellulose as a...
The main aim of present work was to formulate and evaluate sustain release matrix tablets of Aceclof...
The Matrix Tablets each containing 50 mg of diclofenac sodium are prepared employing kollidonSR by d...
Objective: The present work was aimed at preparation of mesalazine microspheres by a non-aqueous sol...
ABSTRACT The main aim of the present work is to formulate and develop matrix tablets of Propranolol...
ABSTRACT The present work involves the formulation of colon targeted matrix tablet of Mesalazine by...
Mesalamine is a gold standard anti-inflammatory drug used to treat inflammatory bowel illnesses. It'...
In the present investigation an attempt was made to formulate the time and pH dependent drug deliver...
In the present investigation an attempt was made to formulate the time and pH dependent drug deliver...
In the present investigation an attempt was made to formulate the time and pH dependent drug deliver...
The main objective of this research paper is to formulate, evaluate and compare compression-coated t...
Gliclazide was formulated as a hydrophobic matrix sustained release tablet employing HPMC using diff...
The aim of the current work was to formulate as well as evaluate colon targeted matrix tablet using ...
ABSTRACT: Objective: The aim of this study is to develop an enteric coated (coated with Eudragit S-...
Abstract The system of drug delivery mainly depends on targeted therapy synthesis that is the formul...
Eudragit® NM was investigated as a matrix former in combination with microcrystalline cellulose as a...
The main aim of present work was to formulate and evaluate sustain release matrix tablets of Aceclof...
The Matrix Tablets each containing 50 mg of diclofenac sodium are prepared employing kollidonSR by d...
Objective: The present work was aimed at preparation of mesalazine microspheres by a non-aqueous sol...
ABSTRACT The main aim of the present work is to formulate and develop matrix tablets of Propranolol...